Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump

A heat-stable cytotoxic factor produced by Achromobacter xylosoxidans isolated from Brazilian patients with CF is associated with in vitro increased proinflammatory cytokines

(2012) Rebeca P. Mantovani et al.   Journal of Cystic Fibrosis

Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7

(2012) Y. Morita et al.   MICROBIOLOGY-SGM

First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM

(2011) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment

(2011) Winnie Ridderberg et al.   Journal of Cystic Fibrosis

A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams inPseudomonas aeruginosa

(2010) Cédric Muller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005

(2009) Samiya Razvi et al.   CHEST

In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods

(2009) Marisa Almuzara et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients

(2009) C.R. Hansen et al.   Journal of Cystic Fibrosis

Urinary tract infection due toAchromobacter xylosoxidans: Report of 9 cases

(2008) Daniel Tena et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES